Literature DB >> 21700580

Severity of leukoaraiosis determines clinical phenotype after brain infarction.

E M Arsava1, A Bayrlee, M Vangel, N S Rost, J Rosand, K L Furie, A G Sorensen, H Ay.   

Abstract

OBJECTIVE: To determine whether the extent of leukoaraiosis, a composite marker of baseline brain integrity, differed between patients with TIA with diffusion-weighted imaging (DWI) evidence of infarction (transient symptoms with infarction [TSI]) and patients with ischemic stroke.
METHODS: Leukoaraiosis volume on MRI was quantified in a consecutive series of 153 TSI and 354 ischemic stroke patients with comparable infarct volumes on DWI. We explored the relationship between leukoaraiosis volume and clinical phenotype (TIA or ischemic stroke) using a logistic regression model.
RESULTS: Patients with TSI tended to be younger (median age 66 vs 69 years, p = 0.062) and had smaller median normalized leukoaraiosis volume (1.2 mL, interquartile range [IQR] 0.2-4.7 mL vs 3.5 mL, IQR 1.2-8.6 mL, p < 0.001). In multivariable analysis controlling for age, stroke risk factors, etiologic stroke mechanism, infarct volume, and infarct location, increasing leukoaraiosis volume remained associated with ischemic stroke (odds ratio 1.05 per mL, 95%confidence interval 1.02-1.09, p = 0.004), along with infarct volume and infarct location.
CONCLUSION: The probability of ischemic stroke rather than TSI increases with increasing leukoaraiosis volume, independent of infarct size and location. Our findings support the concept that the integrity of white matter tracts connecting different parts of the brain could contribute to whether or not patients develop TSI or ischemic stroke in an event of brain infarction.

Entities:  

Mesh:

Year:  2011        PMID: 21700580      PMCID: PMC3127331          DOI: 10.1212/WNL.0b013e318221ad02

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  36 in total

Review 1.  CT and MRI rating of white matter lesions.

Authors:  Franz Fazekas; F Barkhof; L O Wahlund; L Pantoni; T Erkinjuntti; P Scheltens; R Schmidt
Journal:  Cerebrovasc Dis       Date:  2002       Impact factor: 2.762

2.  Stroke severity in patients with atrial fibrillation.

Authors:  Susana Penado; Marta Cano; Olga Acha; José L Hernández; José A Riancho
Journal:  Am J Med       Date:  2002-05       Impact factor: 4.965

3.  Addition of brain infarction to the ABCD2 Score (ABCD2I): a collaborative analysis of unpublished data on 4574 patients.

Authors:  Matthew F Giles; Greg W Albers; Pierre Amarenco; Murat M Arsava; Andrew Asimos; Hakan Ay; David Calvet; Shelagh Coutts; Brett L Cucchiara; Andrew M Demchuk; S Claiborne Johnston; Peter J Kelly; Anthony S Kim; Julien Labreuche; Philippa C Lavallee; Jean-Louis Mas; Aine Merwick; Jean Marc Olivot; Francisco Purroy; Wayne D Rosamond; Rossella Sciolla; Peter M Rothwell
Journal:  Stroke       Date:  2010-07-15       Impact factor: 7.914

4.  Special report from the National Institute of Neurological Disorders and Stroke. Classification of cerebrovascular diseases III.

Authors: 
Journal:  Stroke       Date:  1990-04       Impact factor: 7.914

5.  Formation of new connexions in adult rat brains after partial deafferentation.

Authors:  P D Wall; M D Egger
Journal:  Nature       Date:  1971-08-20       Impact factor: 49.962

6.  Cerebral white matter lesions, retinopathy, and incident clinical stroke.

Authors:  Tien Yin Wong; Ronald Klein; A Richey Sharrett; David J Couper; Barbara E K Klein; Duan-Ping Liao; Larry D Hubbard; Thomas H Mosley
Journal:  JAMA       Date:  2002-07-03       Impact factor: 56.272

7.  White matter hyperintensity on cranial magnetic resonance imaging: a predictor of stroke.

Authors:  Lewis H Kuller; W T Longstreth; Alice M Arnold; Charles Bernick; R Nick Bryan; Norman J Beauchamp
Journal:  Stroke       Date:  2004-06-03       Impact factor: 7.914

8.  Neural correlates of outcome after stroke: a cross-sectional fMRI study.

Authors:  N S Ward; M M Brown; A J Thompson; R S J Frackowiak
Journal:  Brain       Date:  2003-06       Impact factor: 13.501

9.  Leukoaraiosis predicts the need for intraoperative shunt placement during carotid endarterectomy.

Authors:  Ali Arshad; Nishath Altaf; Stephen Goode; Dorothee P Auer; Shane T MacSweeney
Journal:  Perspect Vasc Surg Endovasc Ther       Date:  2009-10-09

10.  Hypodensity of the cerebral white matter in patients with transient ischemic attack or minor stroke: influence on the rate of subsequent stroke. Dutch TIA Trial Study Group.

Authors:  J C van Swieten; L J Kappelle; A Algra; J C van Latum; P J Koudstaal; J van Gijn
Journal:  Ann Neurol       Date:  1992-08       Impact factor: 10.422

View more
  12 in total

1.  Extreme deep white matter hyperintensity volumes are associated with African American race.

Authors:  Paul A Nyquist; Murat S Bilgel; Rebecca Gottesman; Lisa R Yanek; Taryn F Moy; Lewis C Becker; Jennifer Cuzzocreo; Jerry Prince; David M Yousem; Diane M Becker; Brian G Kral; Dhananjay Vaidya
Journal:  Cerebrovasc Dis       Date:  2014-03-25       Impact factor: 2.762

Review 2.  Clinical neurogenetics: stroke.

Authors:  Natalia S Rost
Journal:  Neurol Clin       Date:  2013-07-17       Impact factor: 3.806

3.  White matter hyperintensity determines ischemic stroke severity in symptomatic carotid artery stenosis.

Authors:  Joomee Song; Keon-Ha Kim; Pyoung Jeon; Young-Wook Kim; Dong-Ik Kim; Yang-Jin Park; Moo-Seok Park; Jong-Won Chung; Woo-Keun Seo; Oh Young Bang; Hakan Ay; Gyeong-Moon Kim
Journal:  Neurol Sci       Date:  2021-01-07       Impact factor: 3.307

4.  Stroke outcomes are worse with larger leukoaraiosis volumes.

Authors:  Wi-Sun Ryu; Sung-Ho Woo; Dawid Schellingerhout; Min Uk Jang; Kyoung-Jong Park; Keun-Sik Hong; Sang-Wuk Jeong; Jeong-Yong Na; Ki-Hyun Cho; Joon-Tae Kim; Beom Joon Kim; Moon-Ku Han; Jun Lee; Jae-Kwan Cha; Dae-Hyun Kim; Soo Joo Lee; Youngchai Ko; Yong-Jin Cho; Byung-Chul Lee; Kyung-Ho Yu; Mi Sun Oh; Jong-Moo Park; Kyusik Kang; Kyung Bok Lee; Tai Hwan Park; Juneyoung Lee; Heung-Kook Choi; Kiwon Lee; Hee-Joon Bae; Dong-Eog Kim
Journal:  Brain       Date:  2016-12-22       Impact factor: 13.501

5.  White matter hyperintensity burden in patients with ischemic stroke treated with thrombectomy.

Authors:  Grégoire Boulouis; Nicolas Bricout; Wagih Benhassen; Marc Ferrigno; Guillaume Turc; Martin Bretzner; Joseph Benzakoun; Pierre Seners; Thomas Personnic; Laurence Legrand; Denis Trystram; Christine Rodriguez-Regent; Andreas Charidimou; Natalia S Rost; Serge Bracard; Charlotte Cordonnier; Catherine Oppenheim; Olivier Naggara; Hilde Henon
Journal:  Neurology       Date:  2019-09-13       Impact factor: 9.910

6.  Determinants of white matter hyperintensity burden differ at the extremes of ages of ischemic stroke onset.

Authors:  Cathy R Zhang; Lisa Cloonan; Kaitlin M Fitzpatrick; Allison S Kanakis; Alison M Ayres; Karen L Furie; Jonathan Rosand; Natalia S Rost
Journal:  J Stroke Cerebrovasc Dis       Date:  2014-11-06       Impact factor: 2.136

7.  Molecular disorganization of axons adjacent to human lacunar infarcts.

Authors:  Jason D Hinman; Monica D Lee; Spencer Tung; Harry V Vinters; S Thomas Carmichael
Journal:  Brain       Date:  2015-01-21       Impact factor: 13.501

8.  Neuroimaging of cerebrovascular disease in the aging brain.

Authors:  Ajay Gupta; Sreejit Nair; Andrew D Schweitzer; Sirish Kishore; Carl E Johnson; Joseph P Comunale; Apostolos J Tsiouris; Pina C Sanelli
Journal:  Aging Dis       Date:  2012-09-19       Impact factor: 6.745

9.  Leukoaraiosis and increased cerebral susceptibility to ischemia: lack of confounding by carotid disease.

Authors:  Ursula G Schulz; Basil E Grüter; Dennis Briley; Peter M Rothwell
Journal:  J Am Heart Assoc       Date:  2013-08-20       Impact factor: 5.501

10.  Preoperative white matter lesions are independent predictors of long-term survival after internal carotid endarterectomy.

Authors:  Niku Oksala; Marianne Jaroma; Juha-Pekka Pienimäki; Tommi Kuorilehto; Teemu Vänttinen; Antti Lehtomäki; Veli-Pekka Suominen; Prasun Dastidar; Kimmo Mäkinen; Timo Erkinjuntti; Juha-Pekka Salenius
Journal:  Cerebrovasc Dis Extra       Date:  2014-06-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.